[1] |
ZHENG Yunxi, YI Xiaofang, XU Congjian.
Progress in the application of non-peptide gonadotropin-releasing hormone antagonist in the treatment of uterine fibroid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 482-487.
|
[2] |
LIU Qian, ZHANG Jianing, ZHANG Shuang, LIU Qinglan, ZHANG Baoyin, SUN Nan.
Comparison of clinical effectiveness and safety between generic and branded dienogest tablets in the treatment of endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 527-534.
|
[3] |
LIU Yuru, WU Wenwen, WANG Gang.
Navafenterol, a new drug for the treatment of chronic obstructive airway disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 401-405.
|
[4] |
LI Mei, LI Qiang.
Recent progress of targeting Nrf2-ferroptosis to treat brain injury after ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 188-197.
|
[5] |
YAN Bingqian, GUO Siwei, LI You, TIAN Miaomei, XU Bing, JIANG Rong, LI Xin.
Development and validation of a method for quantitation of cefepime/avibactam in M-H broth: application to antibacterial activity using in vitro PK/PD Model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 52-60.
|
[6] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|
[7] |
WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng.
Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727.
|
[8] |
LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao.
Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
|
[9] |
LI Hongqin, CAO Limin, JIN Manyi, WANG Jianlong, CHAI Xiaoping, TIAN Miaomiao.
Effects of different dosage forms of Qianzheng powder on facial nerve injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 617-623.
|
[10] |
WU Xiongzhi, WANG Xuan, XU Siqi, JU Xia, WANG Shengbin, CHEN Yongquan.
A comparative investigation of the impact of oral midazolam solution and dexmedetomidine nasal spray on preoperative anxiety in pediatric patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 666-670.
|
[11] |
CAI Zuhuan, DENG Taomei, WEI Naijie, ZHU Dan, QIAN Fei, WANG Guangji, ZHANG Jingwei.
Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 241-248.
|
[12] |
ZHANG Xuejiao, LIU Jieting, LI Luxin, CHEN Peijian, DING Minglu, SUN Mengwei, CHU Yanhui, ZHANG Zhen .
Effects and mechanism of dapagliflozin on myocardial injury in type 1 diabetes mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 257-265.
|
[13] |
LUO Mingjie, LIU Runhan, ZHOU Jie, WANG Zhenlei.
Comparison of common parameter estimation methods in NONMEM 7.5.1.: A case study of ibuprofen injection in Chinese healthy adult population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 290-298.
|
[14] |
WU Zhiyong, LIU Bingrong, LI Bin, TANG Rui.
Value of red blood cell distribution width in predicting early poor neurologic improvement after intravenous thrombolysis in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 307-314.
|
[15] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|